Nemaura Medical Inc. Reports Net Loss of $1.7 Million for the Fourth Quarter
Revenue for Nemaura Medical Inc. in the Fourth Quarter Amounted to $3,017
Nemaura Medical Inc.(NMRD), a leading medical techno logy company, has announced its financial results for the fourth quarter ending December 31, 2022. The company reported a net loss of $1.7 million during the period, accompanied by total revenue of $3,017.
Financial Statements
The condensed consolidated balance sheets for Nemaura Medical Inc. reveal a snapshot of the company's financial position. As of December 31, 2022, the company's assets amounted to $12.96 million, with current assets totaling $10.94 million. Cash reserves stood at $7.34 million, while prepaid expenses and other receivables amounted to $1.22 million. The company reported an inventory value of $2.35 million.
On the liabilities side, Nemaura Medical Inc. reported total liabilities of $22.82 million, with current liabilities reaching $13.22 million. Accounts payable amounted to $171,207, and other liabilities and accrued expenses were recorded at $390,858. The company's stockholders' deficit equity was reported as $9.86 million.
